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Epidemiologic associations between levels
of ambient particulate matter (PM) and mor-
bidity (Burnett et al. 1995; Committee of
Departmental Officers and Expert Advisers
1954; Poloniecki et al. 1997; Schwartz and
Morris 1995; Wichmann et al. 1989) and
mortality (Pope et al. 1992; Schwartz 1994;
Schwartz and Dockery 1992; Wordley et al.
1997) from cardiovascular and pulmonary
diseases in humans have been reported. These
studies have also indicated that groups with
preexisting cardiopulmonary disease appear to
be at highest risk of the acute impacts of PM.
Our laboratory is currently using animal mod-
els of cardiovascular and pulmonary disease to
investigate mechanisms that may be involved
in these findings. One such model is that
induced by monocrotaline (MCT) in rats,
which imparts significant cardiopulmonary
disease (White and Roth 1989). MCT is a
pyrrolizidine alkaloid found in leaves and
seeds of the plant Crotalaria spectabilis. In rats,
administration of MCT causes pulmonary
vascular injury and inﬂammation, pulmonary
hypertension, and right ventricular hyper-
trophy (Meyrick et al. 1980). Many of the
MCT-induced changes in rats are similar to
those seen in certain types of chronic pul-
monary hypertension in humans (Meyrick
and Reid 1979).
Previous studies in our laboratory have
demonstrated acute lung injury with alveolar
inﬂammation in rats, after exposure to residual
oil fly ash (ROFA), an emission source PM
of which the primary toxic component is the
bioavailable metal fraction (Dreher et al. 1997;
Kodavanti et at. 1997a, 1997b). In addition,
studies in our laboratory have demonstrated
enhanced inﬂammation, increased frequency
and severity of cardiac arrhythmias, and
increased mortality after intratracheal instilla-
tion (IT) and inhalation (INH) of ROFA in
rats pretreated with MCT (Kodavanti et al.
1999; Watkinson et al. 1998, 2000). Mortality
and enhanced injury with ROFA INH in this
model have also been reported by Killingsworth
et al. (1997), but the etiology of death was
unknown. Many of the cardiac arrhythmias in
the Watkinson studies appeared consistent
with myocardial hypoxia. We hypothesized
that the cardiac effects might be secondary
to ventilatory and pulmonary gas exchange
impairments. To test this hypothesis, we
measured breathing parameters and diffusing
capacity as indirect measures of gas exchange
competence in unanesthetized, unrestrained
animals as opposed to directly measuring gas
exchange, which requires handling and
arterial cannulation, potentially altering the
validity of results in these compromised rats.
Severe impairments would be self-evident
from vastly abnormal values, but less dra-
matic changes might suggest the transient yet
signiﬁcant impairments as seen in individuals
with chronic obstructive pulmonary disease.
If coupled with underlying cardiac dysfunc-
tion, these less dramatic changes might be
sufﬁcient to trigger such cardiac events.
Materials and Methods
Animals. Sixty-day-old male Sprague-Dawley
rats (Charles River Breeding Laboratories,
Raleigh, NC) were housed in a facility fully
accredited by the American Association for
Accreditation of Laboratory Animal Care.
Food (Purina Rodent Lab Chow, St. Louis,
MO) and water were available ad libitum.
Particles. ROFA had been previously col-
lected using a Teflon-coated fiber filter at a
temperature of 204°C by Southern Research
Institute (Birmingham, AL) downstream from
the cyclone of a power plant in Florida burn-
ing low-sulfur no. 6 residual oil. The mass
mean aerodynamic diameter of ROFA was
1.95 µm, and the geometric mean was
2.19 µm (Dreher et al. 1997). For IT expo-
sures, ROFA was suspended in sterile
0.9% sodium chloride solution (saline, SAL;
Fujisawa USA Inc., Deerﬁeld, IL) at a concen-
tration of 8.3 mg/mL. ROFA has been tested
and found to be free of endotoxin (Cape Cod
Associates, South Yarmouth, MA).
Treatment. MCT (Sigma Chemical Co.,
St. Louis, MO) was dissolved in 1.0 M
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Preexistent cardiopulmonary disease in humans appears to enhance susceptibility to the adverse
effects of ambient particulate matter. Previous studies in this laboratory have demonstrated
enhanced inﬂammation and mortality after intratracheal instillation (IT) and inhalation (INH) of
residual oil ﬂy ash (ROFA) in a rat model of pulmonary hypertension induced by monocrotaline
(MCT). The present study was conducted to examine the effects of ROFA in this model on venti-
latory function in unanesthetized, unrestrained animals. Sixty-day-old male CD rats were injected
with MCT (60 mg/kg) or vehicle (VEH) intraperitoneally 10 days before IT of ROFA (8.3 mg/kg)
or saline (SAL) (control) or nose-only INH of ROFA [15 mg/m3 for 6 hr on 3 consecutive days or
air (control)]. At 24 and 72 hr after exposure, rats were studied individually in a simultaneous gas
uptake/whole-body plethysmograph. Lungs were removed at 72 hr for histology. Pulmonary test
results showed that tidal volume (VT) decreased 24 hr after IT of ROFA in MCT-treated rats.
Breathing frequency, minute volume (VE), and the ventilatory equivalent for oxygen increased in
MCT- and VEH-treated rats 24 hr after IT or INH of ROFA and remained elevated 72 hr
post-IT. O2 uptake (VO2) decreased after IT of ROFA in MCT-treated rats. Carbon monoxide
uptake decreased 24 hr after IT of ROFA, returning to control values in VEH-treated rats but
remaining low in MCT-treated rats 72 hr post-IT. ROFA exposure induced histologic changes
and abnormalities in several ventilatory parameters, many of which were enhanced by MCT treat-
ment. Key words: air pollution, cardiopulmonary, monocrotaline, particle, residual oil ﬂy ash, ven-
tilation. Environ Health Perspect 112:872–878 (2004). doi:10.1289/ehp.6583 available via
http://dx.doi.org/ [Online 17 February 2004]hydrochloric acid, diluted with sterile distilled
water, and adjusted to a pH of 7.0 with sterile
1.0 M NaOH; the final concentration was
adjusted to 60 mg/mL. Twelve rats were
injected intraperitoneally with this MCT sus-
pension (60 mg/kg) 10 days before IT, and
another 12 rats were injected intraperitoneally
with this MCT suspension (60 mg/kg) 10 days
before INH. Twelve control rats were injected
intraperitoneally with sterile water adjusted to
a pH of 7.0 (vehicle, VEH; 1 mL/kg) 10 days
before IT, and another 12 control rats were
injected intraperitoneally with sterile water
adjusted to a pH of 7.0 (VEH; 1 mL/kg)
10 days before INH exposure.
IT exposure. IT was performed as previ-
ously described (Dreher et al. 1997). ROFA
suspension (8.3 mg/kg) or SAL (control) was
instilled intratracheally (1 mL/kg) in six rats
that had been treated with MCT 10 days
before and six rats that had been treated with
VEH 10 days before they were exposed to
ROFA. Six rats that had been treated with
MCT 10 days before, and six rats that had
been treated with VEH 10 days before, were
exposed to SAL.
INH exposure. Nose-only INH exposure
was performed as previously described
(Kodavanti et al. 1999; Ledbetter et al. 1998)
for 6 hr on 3 consecutive days at a concen-
tration of 15 mg/m3 ROFA or air (control).
Brieﬂy, the generator, designed on the princi-
ple of a carpenter’s chalk line, used a continu-
ously moving string to carry adherent particles
upward from a reservoir containing ROFA.
Aerosolization was accomplished using com-
pressed air to pulse-dislodge particles from the
string into the dilution air stream. Six rats that
had been treated with MCT 10 days before,
and six rats that had been treated with VEH
10 days before, were exposed to ROFA. Six
rats that had been treated with MCT 10 days
before, and six rats that had been treated with
VEH 10 days before were exposed to air. The
anticipated cumulative dose of ROFA was
calculated based on the mean weight of rats
(300 g) at the time of exposure.
Ventilation measurements. A gas uptake/
whole body plethysmograph system (Figure 1)
was used for unrestrained simultaneous meas-
urement of all ventilation parameters. The gas
uptake chamber (McGee et al. 1995) is a
closed, recirculated system that provides oxy-
gen uptake rate (VO2; milliliters per minute per
kilogram) and carbon monoxide uptake rate.
Attachment of a differential pressure trans-
ducer (model DP45; Validyne Engineering
Corp., Northridge, CA) allows the chamber to
serve as a whole-body plethysmograph (Wong
and Alarie 1982) for measurement of breathing
frequency (breaths/min), tidal volume (VT;
milliliters per breath), and minute volume (VE;
milliliters per minute). The barometric meas-
urement algorithm and syringe pump calibrator
used for VT were as described by Perkins et al.
(1996). Rats were studied individually at
24 and 72 hr postexposure. After the two expo-
sure scenarios, six rats from each of the four
groups were studied: a) VEH-treated/SAL IT
or air INH, b) VEH-treated/ROFA IT or
ROFA INH, c) MCT-treated/SAL IT or air
INH, d) MCT-treated/ROFA IT or ROFA
INH. After a 20-min acclimation period, VO2,
breathing frequency, VT, and VE were meas-
ured for 40 min and averaged. Two milliliters
of pure CO was then injected into the exposure
chamber, and the CO concentration (parts per
million) was measured continuously using a
nondispersive single-beam infrared technique,
with alternate modulation of the sample and
reference cells (model 8501-5CA; Bendix
Corp., Lewisburg, WV) and recorded on a strip
chart (model BD 111; Kipp and Zonen, Delft,
Holland). The CO analyzer was calibrated by a
static dilution technique (Nelson 1972) of a
certiﬁed gas standard (1,200 ppm CO in nitro-
gen; National Specialty Gases, Durham, NC).
The initial concentration of CO within the
chamber after injection was 1,100 ppm. A ratio
of the CO concentration in the plethysmo-
graph at 10 min after injection (C10) to the
concentration of CO in the plethysmograph
immediately after injection (C0), C10:C0 (unit-
less), was used as an index of the respiratory
CO uptake (Yokoyama 1984). The ventilatory
equivalent for O2 was calculated as VE:VO2
(unitless; Mauderly 1995).
Histopathology. At the completion of the
72 hr postexposure ventilation measurements,
rats were anesthetized by an intraperitoneal
injection of sodium pentobarbital (50 mg/kg)
and exsanguinated via the abdominal aorta.
The lungs were ﬁxed intratracheally with 4%
paraformaldehyde in phosphate-buffered SAL
(28 mL/kg) and placed in 4% paraformalde-
hyde. After ﬁxation, the tissues were embedded
in parafﬁn and 4-µm-thick midsagittal sections
were mounted and stained with hematoxylin
and eosin (Experimental Pathology Laboratory,
Research Triangle Park, NC). Slides were read
by a pathologist in a blind and random man-
ner. The slides were evaluated for the degree of
a) alveolitis, deﬁned as inﬂammatory changes
manifested principally within the intra-alveolar
space and alveolar zones not contiguous with
alveolar duct regions; b) bronchiolar hyperplasia,
deﬁned as increased size and numbers of epithe-
lial cells within the alveolar duct and terminal
bronchiolar structures; c) bronchiolocentric
inﬂammation, deﬁned as thickening of airway
wall with inﬂammatory cells and inﬂammatory
changes in the centriacinar zone; d) angiocentric
inﬂammation, deﬁned as thickening of vascular
structures and perivascular tissue with inﬂam-
matory cells; e) alveolar hyperplasia, deﬁned as
increased numbers of alveolar type II cells lining
alveolar septal regions; and f ) alveolar septal
thickening, defined as increased numbers of
inﬂammatory cells and expansion of interstitial
tissue within alveolar septal walls. The following
code was used for scoring: 0, no lesions pre-
sent; 1, minimal lesions present; 2, mild lesions
present; 3, moderate lesions present; 4, severe
lesions present.
Statistical analysis. Results are expressed
as means ± SE. The data were analyzed using
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Figure 1. Schematic of simultaneous gas uptake chamber/whole body plethysmograph. Modified from
McGee et al. 1995.
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controla general linear model. A multivariate analysis
of variance was performed simultaneously
evaluating the effect of MCT and ROFA on
the response variables. For significant find-
ings, a univariate analysis of variance was per-
formed on each of the dependent variables.
Pairwise comparisons were performed as sub-
sets of the overall analysis. A Bonferroni cor-
rection was applied to the multiple pairwise
comparisons. The level of signiﬁcance was set
at 0.05.
Results
IT exposure. Two of the six MCT-treated rats
that were instilled with ROFA intratracheally
died between the 24 hr and 72 hr post-IT ven-
tilatory measurements. Breathing frequency
increased by approximately one-half at 24 hr
and remained elevated by the same amount at
72 hr after IT of ROFA in both VEH- and
MCT-treated rats (Figure 2A). VT decreased
slightly 24 hr after IT of ROFA in MCT-
treated rats (Figure 2B) but otherwise showed
little change. VE increased 24 and 72 hr after
IT of ROFA in both VEH- and MCT-treated
rats (Figure 2C), largely due to the increases in
breathing frequency. The impact of ROFA on
VE at either time point for the healthy (VEH-
treated) and MCT-treated rats was similar.
Impairment in the lung’s overall ability to
transfer gas into the blood was indicated by a
significant and similar increase in C10:C0 of
approximately 10–15% by both MCT treat-
ment and IT of ROFA at 24 hr post-IT
(Figure 3A). At 72 hr post-IT, C10:C0 in the
VEH-treated/ROFA-instilled rats had begun
to subside toward control and was no longer
significantly different. At 72 hr post-IT,
C10:C0 was similarly increased by MCT treat-
ment in the SAL-instilled rats as at 24 hr.
However, in the MCT-treated/ROFA-instilled
rats at 72 hr, C10:C0 was increased more than
additively, but to a similar degree as at 24 hr
(Figure 3A). This pattern of gas transfer impair-
ment was reﬂected in VO2, which was decreased
by MCT treatment (~10%) alone but decreased
further (> 20%) with the addition of IT of
ROFA at 24 hr post-IT (Figure 3B). At 72 hr
post-IT, VO2 remained decreased by ROFA
in MCT-treated rats only (Figure 3B); effects
were similar at 24 and 72 hr. The ventilatory
equivalent for O2 increased substantially
24 and 72 hr after IT of ROFA, synergisti-
cally so in MCT-treated rats (Figure 4).
MCT treatment resulted in significant
alveolitis, angiocentric inflammation, and
alveolar septal thickening (Table 1, Figure 5).
IT of ROFA induced alveolitis, bronchiolar
hyperplasia, bronchiolocentric inﬂammation,
angiocentric inﬂammation, alveolar hyperplasia,
and alveolar septal thickening in both VEH-
and MCT-treated rats (Table 1, Figure 5).
INH exposure. INH of ROFA produced
several changes in breathing parameters at 24 hr
after exposure. Breathing frequency increased by
approximately 50% at 24 hr in both VEH- and
MCT-treated rats (Figure 6A). MCT alone
depressed VT slightly but not signiﬁcantly at
24 hr; however, this difference reached signiﬁ-
cance at the 72 hr time point (Figure 6B) but in
general showed little change. VE increased 24 hr
after INH of ROFA in both VEH- and MCT-
treated rats (Figure 6C), consistent with the rise
in breathing frequency and small change in VT.
The frequency, VT, and VE results were very
similar for both the IT and INH studies. The
index of respiratory CO uptake (C10:C0)
increased in MCT-treated rats exposed to air
compared with VEH-treated rats exposed to air
24 and 72 hr after air exposure (Figure 7A);
however, the magnitudes of C10:C0 increases for
the INH study were only half those of the IT
study. VO2 decreased in MCT-treated rats
exposed to air compared with VEH-treated rats
exposed to air 72 hr after air exposure (Figure
7B). The VO2 effects for MCT-treated rats were
much smaller for the INH study relative to the
Article | Gardner et al.
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Figure 4. The ventilatory equivalent for O2 (VE:VO2)
increased after IT of ROFA. Results are expressed
as mean ventilatory equivalent for O2 ± SE. Groups
that are significantly different are denoted by the
same symbol (i.e., *, **, #).
Figure 3. (A) C10:C0 increased by MCT treatment and after IT of ROFA at 24 hr. At 72 hr, C10:C0 increased by
MCT treatment and after IT of ROFA in MCT-treated rats only. Results are expressed as mean C10:C0 ± SE.
Groups that are signiﬁcantly different are denoted by the same symbol (i.e., *, **, #, ##). (B) VO2 decreased by
MCT treatment and after IT of ROFA in MCT-treated rats only at 24 hr. At 72 hr VO2 decreased after IT of ROFA
in MCT-treated rats only. Results are expressed as mean VO2 ± SE. Groups that are signiﬁcantly different are
denoted by the same symbol (i.e., **, #, ##).
Figure 2. (A) Breathing frequency (f) increased after IT of ROFA. Results are expressed as mean frequency ± SE. Groups that are signiﬁcantly different are denoted by
the same symbol (i.e., *, #). (B) VT decreased 24 hr after IT of ROFA in MCT-treated rats. Results are expressed as mean VT ± SE. Groups that are signiﬁcantly different
are denoted by the same symbol (i.e., **). (C) VE increased after IT of ROFA. Results are expressed as mean VE ± SE. Groups that are signiﬁcantly different are denoted
by the same symbol (i.e., *, #).
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**IT study. The ventilatory equivalent for O2
increased substantially 24 hr after INH of
ROFA in both VEH- and MCT-treated rats
but was much less at 72 hr (Figure 8).
MCT treatment produced signiﬁcant alve-
olitis and angiocentric inﬂammation (Table 2,
Figure 9). INH exposure of ROFA induced
alveolitis, bronchiolar hyperplasia, bronchiolo-
centric inﬂammation, and alveolar septal thick-
ening in both VEH- and MCT-treated rats
(Table 2, Figure 9). The combination of MCT
treatment and ROFA exposure appeared to
have a greater than additive effect on bronchio-
lar and alveolar hyperplasia (Table 2, Figure 9).
Discussion
The present study was conducted to compare
ventilatory function and histology in a rat
model of MCT-induced pulmonary vasculitis
and hypertension after exposure to the model
emission particle, ROFA, by IT or nose-only
INH. ROFA is emitted from oil-ﬁred power
plants, and although it represents a very small
fraction of ambient PM, its metal sulfate com-
position has been associated with the toxic
effects of various model and ambient PM
administered to experimental animals in rela-
tively high doses (Costa and Dreher 1997;
Dreher et al. 1997). The model has proved
useful in the study of PM-associated health
effects and mechanisms. Although the issue of
dose imparts uncertainty in the interpretation
of the effects seen in experimental animals, the
coherence in the effects seen in animals with
model and ambient PM lends credence to its
use to explore mechanistic questions surround-
ing rare effects seen in the exposed human
population (Costa and Dreher 1997; Dye et al.
2001). The inﬂammatory responses to the IT
dose of ROFA used in this study have been
well characterized in healthy and compromised
animal models and have been compared with
INH of comparable doses of the metal sulfates
themselves (Campen et al. 2002). The esti-
mated cumulative dose of ROFA resulting
from the INH exposure based on 15% deposi-
tion was 3.03 mg/kg. This INH dose also
compares with other INH exposures that have
shown altered cardiac function in cardiac-
compromised rats (Kodavanti et al. 2000).
Although no mortality has been observed in
our laboratory with these high INH exposures,
mortality has been reported with a similar
ROFA exposure in MCT rats at only approxi-
mately 500 µg/m3 (Killingsworth et al. 1997).
Thus, we tested the hypothesis of altered
ventilation and gas exchange (represented by
C10:C0, a steady-state diffusion measure), using
Article | Particles induce ventilatory abnormalities
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Table 1. Mean scores of pathologic lesions.a
Lesion VEH-SAL VEH-ROFA MCT-SAL MCT-ROFA
Alveolitis 0.5*,** 2.8* 1.4**,## 3.5##
Bronchiolar hyperplasia 0* 2.3* 0## 3.2##
Bronchiolocentric inﬂammation 0* 2.2* 0.4## 2.5##
Angiocentric inﬂammation 0*,** 1.3*,# 2.0**,## 2.8#,##
Alveolar hyperplasia 0* 3.2*,# 0.6## 1.8#,##
Alveolar septal thickening 0*,** 3.0* 1.0**,## 2.5##
aLung sections were taken from rats (n = 4 for MCT-ROFA; n = 6 for each of the other three groups) 13 days after injection
of VEH or MCT and 72 hr after IT of SAL or ROFA. Slides were read by a pathologist in a blind and random manner and the
following code was used for scoring: 0, not present, 1, minimal, 2, mild, 3, moderate, 4, severe. Results are expressed as
mean scores. *,**,#,##Groups that are signiﬁcantly different are denoted by the same symbol.
Figure 6. (A) Breathing frequency (f) increased after INH of ROFA at 24 hr. At 72 hr, frequency was increased in MCT-air–treated rats compared with those treated
with VEH-air. Results are expressed as mean frequency ± SE. Groups that are signiﬁcantly different are denoted by the same symbol (i.e., *, #, ##). (B) VT decreased
in MCT-air–treated rats compared with those treated with VEH-air at 72 hr. Results are expressed as mean VT ± SE. Groups that are signiﬁcantly different are
denoted by the same symbol (i.e., ##). (C) VE increased after INH of ROFA at 24 hr. Results are expressed as mean VE ± SE. Groups that are signiﬁcantly different are
denoted by the same symbol (i.e., *, #).
Figure 5. Light micrographs of lung tissue from rats 13 days after injection of VEH or MCT and 72 hr after IT
of SAL or ROFA. (A) VEH-SAL. Scale bar, 70 µm. (B) VEH-ROFA. Scale bar, 55 µm. (C) MCT-SAL. Scale bar,
35 µm. (D) MCT-ROFA. Scale bar, 35 µm. (B) is an example of bronchiolocentric inﬂammation, whereas (C) is
an example of angiocentric inflammation. The tissue in photomicrograph (D) demonstrates angiocentric
inﬂammation, alveolar hyperplasia, and alveolitis.
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D Cwhat in our hands would be a worst-case
scenario, to assess the likely involvement of
altered physiology in the systemic outcomes
observed.
IT ROFA exposure of MCT-treated rats
has been shown to produce apparent hypoxia-
associated cardiac dysfunction (Watkinson
et al. 1998), leading to arrhythmias and death
(~50%). Concurrent inflammation and ede-
matous injury are observed under these study
conditions. Analogous ﬁndings regarding mor-
tality and histology reported by Killingsworth
et al. (1997) at much lower exposure concentra-
tions appear at ﬁrst at odds with the doses used
by Watkinson and coworkers but may repre-
sent differences in degree of disease. However,
mortality was observed by Watkinson and col-
leagues at doses as low as 250 µg. The IT expo-
sure was conducted initially as a deﬁnitive test
of the feasibility of the impaired diffusion
hypothesis and the merit of further analysis in
the INH study. The INH exposure, although
clearly high based on ambient levels, more
closely represents occupational exposures to
boilermakers where airway and lung dysfunc-
tion have been reported (Hauser et al. 1995).
The MCT model of pulmonary hyperten-
sion presents with features of acute respiratory
inﬂammatory disease with altered respiratory
function and circulatory effects (Meyrick
et al. 1980). Many of the MCT-induced
changes in rats are similar to those seen in pri-
mary and certain other types of chronic pul-
monary hypertension in humans, such as
occurs with chronic bronchitis and emphy-
sema, cystic fibrosis, and, when advanced,
acute respiratory distress syndrome (Meyrick
and Reid 1979). This model was induced to
represent a susceptible population with sys-
temic cardiopulmonary stress and impairment
to address a potential mechanistic explanation
for the epidemiologic associations reported
between exposure to ambient PM and hospital
admissions (Burnett et al. 1995; Wichmann
et al. 1989) and mortality (Schwartz 1994;
Schwartz and Dockery 1992; Wordley et al.
1997) in humans suffering from preexisting
cardiopulmonary disease.
As predicted from previous studies, two of
the six rats treated with MCT died between
24 and 72 hr after IT of ROFA (Kodavanti
et al. 1999; Watkinson et al. 1998). ROFA
itself imparted some degree of ventilatory
dysfunction in healthy controls, but these
effects were most notable in rats pretreated
with MCT and therefore cardiopulmonarily
compromised. Breathing frequency was dra-
matically increased after IT of ROFA in
both control and MCT-treated rats, but VT
decreased significantly only in MCT-treated
rats 24 hr postexposure. The alterations in VE
(breathing frequency × VT) paralleled those of
breathing frequency. The etiology of these
alterations is uncertain and could be secondary
to the inﬂammatory injury or perhaps related
to direct and/or indirect (via the degree of
lung injury) stimulation of irritant C-ﬁbers in
the tracheobronchial tree and/or vagal non-
myelinated fibers in the pulmonary acinus
(Costa and Schelegle 1999).
The C10:C0 ratio (index of the respiratory
CO uptake), inversely related to CO-diffusing
capacity, a measure of the lung’s overall ability
to transfer gas into the blood, was increased by
MCT treatment, indicating impaired gas trans-
port. An analogous decrease in CO-diffusing
capacity has been previously reported in MCT-
treated rats (Lai et al. 1991). Twenty-four hours
after ROFA exposure, C10:C0 increased in both
control and MCT-treated rats. However, at
72 hr postexposure, a signiﬁcant and more than
additive increase persisted in the MCT-treated
but not control rats. VO2 was likewise decreased
by MCT treatment and decreased further in a
synergistic manner after ROFA exposure. The
ventilatory equivalent for O2 (VE:VO2) was
only slightly (not significantly) increased by
MCT treatment. ROFA IT alone signifi-
cantly increased this parameter of ventilatory
insufficiency but, when overlaid upon the
MCT pretreatment and associated lung dis-
ease, resulted in a substantial and apparent
synergistic increase. This ratio of volume of
air breathed per unit of O2 consumed is a
somewhat crude but useful index of the over-
all efficiency of ventilation indicating a
reduced uptake of O2 per volume of air
breathed (Mauderly 1995). The alterations in
C10:C0, VO2, and the ventilatory equivalent
for O2 indicate that ROFA instillation
hinders the lung’s overall ability to transfer
gas into the blood, and MCT pretreatment
further impaired its ability.
It is difficult to relate these changes
directly to cardiac hypoxia, because blood gas
measures were not taken and likely would not
have been very elucidating because of probable
sympathetic stress interplay. However, as with
patients with chronic obstructive pulmonary
disease who have seemingly mild or moderate
diffusion impairments, there may be signifi-
cant ventilation/perfusion mismatching and
episodic hypoxia with other cardiopulmonary
stressors or demands. Thus these changes may
be responsible, at least in part, for some of the
arrhythmias and electrocardiographic changes
that were noted after ROFA exposure in rats
similarly studied in our laboratory (Watkinson
et al. 1998). Electrocardiographic abnormali-
ties in these studies included bradycardia,
depressed S-T segment area, and high peaked
T-waves, changes associated with hypoxia.
Arrhythmias occurred in both control and
MCT-treated rats after ROFA exposure; how-
ever, the frequency and severity were greatly
exacerbated by MCT treatment, with half of
the MCT-treated rats progressing to death.
Histologically in our IT study, ROFA
treatment alone induced minimal to mild
angiocentric inﬂammation, mild to moderate
bronchiolocentric inﬂammation and bronchi-
olar and alveolar hyperplasia, alveolitis, and
alveolar septal thickening in VEH-treated
rats. The MCT treatment alone induced min-
imal to mild angiocentric inﬂammation, alve-
olitis, and alveolar septal thickening. In
MCT-treated rats, ROFA induced minimal
to mild alveolar hyperplasia, mild to moderate
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Figure 7. (A) C10:C0 increased in MCT-air–treated rats compared with those treated with VEH-air at 24 and
72 hr. Results are expressed as mean C10:C0 ± SE. Groups that are signiﬁcantly different are denoted by the
same symbol (i.e., ##). (B) VO2 decreased in MCT-air–treated rats compared with those treated with VEH-air
at 72 hr. Results are expressed as mean VO2 ± SE. Groups that are signiﬁcantly different are denoted by the
same symbol (i.e., ##).
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Figure 8. The ventilatory equivalent for O2 (VE:VO2)
increased after INH of ROFA at 24 hr. Results are
expressed as mean ventilatory equivalent for O2 ±
SE. Groups that are significantly different are
denoted by the same symbol (i.e., *, **).
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**bronchiolocentric inﬂammation, angiocentric
inﬂammation and alveolar septal thickening,
and moderate to severe alveolitis and bronchi-
olar hyperplasia. These histologic changes may
also have contributed to the abnormalities in
gas exchange.
Regarding the comparison of the modes of
ROFA exposure, ROFA INH affected many of
the same ventilatory parameters observed after
the IT route, but the changes generally were less
dramatic, most likely an effect of dose. In con-
trast to IT, however, there was no clear aug-
mentation of effects associated with MCT
pretreatment. Breathing frequency was dramat-
ically increased 24 hr after ROFA INH in both
control and MCT-treated rats, surprisingly sim-
ilar to those observed in the IT study, but there
were no signiﬁcant changes in VT after INH.
Thus, changes in VE paralleled closely those of
breathing frequency. As in the IT exposure,
pretreatment with MCT resulted in impaired
gas exchange as indicated by a baseline increase
in C10:C0 and a decrease in VO2; however,
there were no additional changes associated
with ROFA INH exposure. The ventilatory
equivalent for O2 increased signiﬁcantly 24 hr
after ROFA exposure in both control and
MCT-treated rats, to a similar extent to that
observed in the IT study. Histologically, ROFA
alone induced minimal to mild bronchiolar
hyperplasia and bronchiolocentric inﬂamma-
tion, alveolitis, and alveolar septal thickening,
whereas MCT pretreatment alone induced
minimal to mild angiocentric inflammation
and alveolitis. The combination of MCT treat-
ment and ROFA exposure, however, resulted
in apparent synergistic severity of bronchiolar
and alveolar hyperplasia. The nature of the his-
tologic changes after INH of ROFA were simi-
lar to those observed after IT of ROFA, but
the degree of severity was less with the excep-
tion of alveolar hyperplasia, which was more
severe in MCT-treated rats.
In this study, ROFA induced histologic
changes and abnormalities in several ventilatory
parameters, many of which were enhanced by
MCT treatment. Although the overall results of
the INH study were not quite as marked as
those observed in the IT study based on dose,
the 24-hr results were comparable for breathing
frequency, VE, and the ventilatory equivalent for
O2, and in MCT-treated rats for the histologic
change of alveolar hyperplasia, demonstrating
that the INH route of a smaller dose (2.7 times
less than the IT exposure) can cause signiﬁcant
effects. The observed ventilatory abnormalities
indicative of impaired gas transfer capacity of
the lung may be responsible, at least in part, for
the apparent hypoxia-associated electrocardio-
graphic changes and arrhythmias previously
reported in our laboratory after ROFA expo-
sure in normal and MCT-pretreated rats. These
ventilatory and gas exchange abnormalities rep-
resent one potential mechanism involved in
the cardiac outcomes revealed by epidemio-
logic associations linking PM with morbidity
and mortality from cardiopulmonary disease.
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Figure 9. Light micrographs of lung tissue from rats 15 days after injection of VEH or MCT and 72 hr after
INH of air or ROFA. (A) VEH-air. (B) VEH-ROFA. (C) MCT-air. (D) MCT-ROFA. Scale bars, 70 µm.
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